How GLP1s are changing the ways Americans buy medicine

Washington Post – Politics:

Consumers are paying in cash in a hotly competitive marketplace, creating a rare phenomenon for a relatively new class of prescription drugs: falling prices.

This post first appeared in Washington Post – Politics. Read the original article.